Insights from
UBC's Expert Voices

UBC talked to Pharmaceutical Commerce about what artificial intelligence capabilities could do to impact patient access in 2024 and beyond.

In the realm of pharmaceuticals, regulatory compliance is paramount to ensure patient safety. With the complex environment of safety reporting, several vendors may be involved at global and local levels for performing submission activities to health authorities, ethics committees and investigators. Director of UBC Global Case Processing, Myrto Ioannidi and UBC Team Manager, Esther Aparicio review […]

Clinical trials provide a limited view of patient experience but this can be expanded through tokenization to link pre- and post-trial data.

For most pharmaceutical companies, hiring a PV team will help alleviate some of the work of the existing internal team.

Putting the patient back in patient services means we do more, go deeper, and customize offerings.

UBC is the leading provider of evidence development solutions with expertise in uniting evidence and access.

Providing the patient with choice throughout their journey empowers them to take an active role in therapy initiation and persistence.

REMS readiness is a key component for certain drugs launch plans - are you on top of approval timelines and milestones and IT build needs?

Understand the latest international opinion on the plan, design, and analysis of pharmacoepidemiological safety studies using RWD.